Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, April 22, 2015, 50 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $9.24 to $5,263,003.35.

Highlighted Stocks Traded by Insiders:

KCG Holdings (KCG) - FREE Research Report

Daniel V. Tierney 2011 Trust, who is 10% Owner at KCG Holdings, sold 46,573 shares at $12.58 on April 22, 2015. Following this transaction, the 10% Owner owned 8.5 million shares meaning that the stake was reduced by 0.55% with the 46,573-share transaction.

The shares most recently traded at $12.85, up $0.27, or 2.11% since the insider transaction. Historical insider transactions for KCG Holdings go as follows:

  • 4-Week # shares sold: 239,908
  • 12-Week # shares sold: 764,412
  • 24-Week # shares sold: 764,412

The average volume for KCG Holdings has been 276,600 shares per day over the past 30 days. KCG Holdings has a market cap of $1.4 billion and is part of the financial sector and financial services industry. Shares are up 9.61% year-to-date as of the close of trading on Wednesday.

KCG Holdings, Inc., an independent securities firm, provides various services designed to address trading needs across asset classes, product types, and time zones. The company operates through three segments: Market Making, Global Execution Services, and Corporate and Other. The company has a P/E ratio of 23.6. Currently, there are 2 analysts who rate KCG Holdings a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KCG - FREE

TheStreet Quant Ratings rates KCG Holdings as a sell. Among the areas we feel are negative, one of the most important has been poor profit margins. Get the full KCG Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Hemispherx Biopharma (HEB) - FREE Research Report

Carter William A, who is Ceo at Hemispherx Biopharma, bought 100,000 shares at $0.24 on April 22, 2015. Following this transaction, the Ceo owned 1.1 million shares meaning that the stake was boosted by 10.52% with the 100,000-share transaction.

The shares most recently traded at $0.26, up $0.02, or 7.69% since the insider transaction. Historical insider transactions for Hemispherx Biopharma go as follows:

  • 4-Week # shares bought: 300,000
  • 12-Week # shares bought: 300,000
  • 24-Week # shares bought: 300,000

The average volume for Hemispherx Biopharma has been 1.9 million shares per day over the past 30 days. Hemispherx Biopharma has a market cap of $51.6 million and is part of the health care sector and drugs industry. Shares are down 4.04% year-to-date as of the close of trading on Wednesday.

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. Currently, there are no analysts who rate Hemispherx Biopharma a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HEB - FREE

TheStreet Quant Ratings rates Hemispherx Biopharma as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity and generally disappointing historical performance in the stock itself. Get the full Hemispherx Biopharma Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Oxford Industries (OXM) - FREE Research Report

Pillow Terry R, who is Ceo, Tommy Bahama Group at Oxford Industries, sold 2,445 shares at $80.03 on April 22, 2015. Following this transaction, the Ceo, Tommy Bahama Group owned 38,345 shares meaning that the stake was reduced by 5.99% with the 2,445-share transaction.

The shares most recently traded at $79.86, down $0.17, or 0.22% since the insider transaction. Historical insider transactions for Oxford Industries go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 13,537
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 13,537
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 13,537

The average volume for Oxford Industries has been 182,000 shares per day over the past 30 days. Oxford Industries has a market cap of $1.3 billion and is part of the consumer goods sector and consumer non-durables industry. Shares are up 43.85% year-to-date as of the close of trading on Wednesday.

Oxford Industries, Inc., an apparel company, designs, sources, markets, and distributes products of company-owned lifestyle brands, licensed, and private labels apparel products worldwide. The stock currently has a dividend yield of 1.25%. The company has a P/E ratio of 28.8. Currently, there are 3 analysts who rate Oxford Industries a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OXM - FREE

TheStreet Quant Ratings rates Oxford Industries as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, reasonable valuation levels and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Oxford Industries Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

null